Showing results (311-320 of 7,001) with videos related to
Sort By:
Pageof 701
Current Medical Research and Opinion|January 1, 1981
Once daily flupenthixol in the treatment of elderly depressed patients: a multi-centre trial in general practiceJ C Vallé-Jones, D J SwarbrickCurrent Medical Research and Opinion|January 1, 1981
Six-month, double-blind comparison of sodium meclofenamate ("Meclomen') with buffered aspirin in the treatment of rheumatoid arthritisJ D GowansCurrent Medical Research and Opinion|August 27, 2021
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparisonRachel H Bhak, Nikita Mody-Patel, Scott B Baver, et al.Current Medical Research and Opinion|June 17, 2020
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitorsShaheenah Dawood, Joanne Wing-Yan Chiu, Chiun-Sheng Huang, et al.Current Medical Research and Opinion|August 20, 2021
Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative reviewGuillaume Becker, Fabien Rougerie, Amelia-Naomi Sabo, et al.Current Medical Research and Opinion|January 1, 1987
The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritisE M Grace, J M Rosenfeld, G D Sweeney, et al.Current Medical Research and Opinion|January 1, 1987
Bezafibrate and fenofibrate in type II diabetics with hyperlipoproteinaemiaR Smud, B SermukslisCurrent Medical Research and Opinion|May 27, 2020
Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescriptionFrancisco Villegas Estévez, María Dolores López Alarcón, Alberto Alonso Babarro, et al.Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.Current Medical Research and Opinion|August 25, 2021
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010-2018Piaopiao Li, Rahul Patel, Jingchuan Guo, et al.Pageof 701